Literature DB >> 20388805

Id2 promotes tumor cell migration and invasion through transcriptional repression of semaphorin 3F.

Silvia Coma1, Dhara N Amin, Akio Shimizu, Anna Lasorella, Antonio Iavarone, Michael Klagsbrun.   

Abstract

Id proteins (Id1 to Id4) are helix-loop-helix transcription factors that promote metastasis. It was found that Semaphorin 3F (SEMA3F), a potent inhibitor of metastasis, was repressed by Id2. High metastatic human tumor cell lines had relatively high amounts of Id2 and low SEMA3F levels compared with their low metastatic counterparts. No correlation between metastatic potential and expression of the other Id family members was observed. Furthermore, ectopic expression of Id2 in low metastatic tumor cells downregulated SEMA3F and, as a consequence, enhanced their ability to migrate and invade, two requisite steps of metastasis in vivo. Id2 overexpression was driven by the c-myc oncoprotein. SEMA3F was a direct target gene of the E47/Id2 pathway. Two E-box sites, which bind E protein transcription factors including E47, were identified in the promoter region of the SEMA3F gene. E47 directly activated SEMA3F promoter activity and expression and promoted SEMA3F biological activities, including filamentous actin depolymerization, inactivation of RhoA, and inhibition of cell migration. Silencing of SEMA3F inhibited the E47-induced SEMA3F expression and biological activities, confirming that these E47-induced effects were SEMA3F dependent. E47 did not induce expression of the other members of the SEMA3 family. Id2, a dominant-negative inhibitor of E proteins, abrogated the E47-induced SEMA3F expression and biological activities. Thus, high metastatic tumor cells overexpress c-myc, leading to upregulation of Id2 expression; the aberrantly elevated amount of Id2 represses SEMA3F expression and, as a consequence, enhances the ability of tumor cells to migrate and invade. (c)2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20388805      PMCID: PMC2862101          DOI: 10.1158/0008-5472.CAN-09-3048

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  47 in total

Review 1.  Rho and Rac take center stage.

Authors:  Keith Burridge; Krister Wennerberg
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

2.  Regulation of the expression of cyclin-dependent kinase inhibitor p21 by E2A and Id proteins.

Authors:  S Prabhu; A Ignatova; S T Park; X H Sun
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

3.  Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.

Authors:  R B Jenkins; J Qian; M M Lieber; D G Bostwick
Journal:  Cancer Res       Date:  1997-02-01       Impact factor: 12.701

4.  The helix-loop-helix protein Id2 is overexpressed in human pancreatic cancer.

Authors:  J Kleeff; T Ishiwata; H Friess; M W Büchler; M A Israel; M Korc
Journal:  Cancer Res       Date:  1998-09-01       Impact factor: 12.701

5.  Id-1 and Id-2 are overexpressed in pancreatic cancer and in dysplastic lesions in chronic pancreatitis.

Authors:  H Maruyama; J Kleeff; S Wildi; H Friess; M W Büchler; M A Israel; M Korc
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

6.  Distinct 3p21.3 deletions in lung cancer and identification of a new human semaphorin.

Authors:  J Roche; F Boldog; M Robinson; L Robinson; M Varella-Garcia; M Swanton; B Waggoner; R Fishel; W Franklin; R Gemmill; H Drabkin
Journal:  Oncogene       Date:  1996-03-21       Impact factor: 9.867

7.  The helix-loop-helix protein Id-2 enhances cell proliferation and binds to the retinoblastoma protein.

Authors:  A Iavarone; P Garg; A Lasorella; J Hsu; M A Israel
Journal:  Genes Dev       Date:  1994-06-01       Impact factor: 11.361

8.  Semaphorin-3F is an inhibitor of tumor angiogenesis.

Authors:  Ofra Kessler; Niva Shraga-Heled; Tali Lange; Noga Gutmann-Raviv; Edmond Sabo; Limor Baruch; Marcelle Machluf; Gera Neufeld
Journal:  Cancer Res       Date:  2004-02-01       Impact factor: 12.701

9.  Human semaphorins A(V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patterns.

Authors:  Y Sekido; S Bader; F Latif; J Y Chen; F M Duh; M H Wei; J P Albanesi; C C Lee; M I Lerman; J D Minna
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

10.  A novel pathway for mammary epithelial cell invasion induced by the helix-loop-helix protein Id-1.

Authors:  P Y Desprez; C Q Lin; N Thomasset; C J Sympson; M J Bissell; J Campisi
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

View more
  44 in total

Review 1.  Semaphorins in angiogenesis and tumor progression.

Authors:  Gera Neufeld; Adi D Sabag; Noa Rabinovicz; Ofra Kessler
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

2.  Adaptive response of vascular endothelial cells to an acute increase in shear stress magnitude.

Authors:  Ji Zhang; Morton H Friedman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-12-02       Impact factor: 4.733

3.  Adaptive response of vascular endothelial cells to an acute increase in shear stress frequency.

Authors:  Ji Zhang; Morton H Friedman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-07-12       Impact factor: 4.733

4.  Gleevec/imatinib, an ABL2 kinase inhibitor, protects tumor and endothelial cells from semaphorin-induced cytoskeleton collapse and loss of cell motility.

Authors:  Vera Procaccia; Hironao Nakayama; Akio Shimizu; Michael Klagsbrun
Journal:  Biochem Biophys Res Commun       Date:  2014-04-20       Impact factor: 3.575

5.  Hypoxia induces tumor and endothelial cell migration in a semaphorin 3F- and VEGF-dependent manner via transcriptional repression of their common receptor neuropilin 2.

Authors:  Silvia Coma; Akio Shimizu; Michael Klagsbrun
Journal:  Cell Adh Migr       Date:  2011-05-01       Impact factor: 3.405

6.  Merlin/NF2 regulates angiogenesis in schwannomas through a Rac1/semaphorin 3F-dependent mechanism.

Authors:  Hon-Kit Wong; Akio Shimizu; Nathaniel D Kirkpatrick; Igor Garkavtsev; Annie W Chan; Emmanuelle di Tomaso; Michael Klagsbrun; Rakesh K Jain
Journal:  Neoplasia       Date:  2012-02       Impact factor: 5.715

7.  Id4 suppresses MMP2-mediated invasion of glioblastoma-derived cells by direct inactivation of Twist1 function.

Authors:  G J Rahme; M A Israel
Journal:  Oncogene       Date:  2014-01-13       Impact factor: 9.867

8.  Inflammation and Lymphedema Are Exacerbated and Prolonged by Neuropilin 2 Deficiency.

Authors:  Patrick Mucka; Nicholas Levonyak; Elena Geretti; Bernadette M M Zwaans; Xiaoran Li; Irit Adini; Michael Klagsbrun; Rosalyn M Adam; Diane R Bielenberg
Journal:  Am J Pathol       Date:  2016-10-14       Impact factor: 4.307

Review 9.  The role of semaphorins and their receptors in vascular development and cancer.

Authors:  Chenghua Gu; Enrico Giraudo
Journal:  Exp Cell Res       Date:  2013-02-17       Impact factor: 3.905

Review 10.  In vivo genome-wide binding of Id2 to E2F4 target genes as part of a reversible program in mice liver.

Authors:  Ivan Ferrer-Vicens; Ángela L Riffo-Campos; Rosa Zaragozá; Concha García; Gerardo López-Rodas; Juan R Viña; Luis Torres; Elena R García-Trevijano
Journal:  Cell Mol Life Sci       Date:  2014-02-28       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.